What one share of VitaSpring Biomedical Co. holds
VitaSpring Biomedical Co. Ltd. (“VitaSpring,” the “Company,” “we,” “us,” or “our”), formerly known as Shemn Corp., was incorporated in the State of Nevada on September 6, 2016. We are a development-stage biomedical company engaged in the research, development, and commercialization of products that promote wellness and a healthy lifestyle.
VitaSpring Biomedical Co.’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-07-31; the balance sheet is as of 2026-07-31.
| Sales | $0.00 |
|---|---|
| Profit | −$0.00 |
| Cash and investments | $0.00 |
| Book value | −$0.02 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $0.00 | −$0.00 | — | — | — | — |
| 2018 | $0.01 | −$0.00 | — | — | — | −$0.00 |
| 2019 | $0.00 | −$0.00 | — | — | — | −$0.00 |
| 2020 | $0.00 | −$0.00 | — | — | — | — |
| 2021 | $0.00 | $0.00 | — | — | — | — |
| 2022 | $0.03 | $0.00 | $0.00 | −$0.00 | — | $0.01 |
| 2023 | $0.00 | −$0.02 | $0.00 | −$0.00 | — | −$0.02 |
| 2024 | $0.00 | −$0.01 | — | — | — | −$0.02 |
| 2025 | $0.00 | −$0.00 | — | — | — | −$0.02 |
| 2026 | $0.00 | −$0.00 | — | — | — | −$0.02 |
Common questions about VitaSpring Biomedical Co.
How much does one share of VitaSpring Biomedical Co. earn?
Over the last 12 months, VitaSpring Biomedical Co. lost $0.00 for each share.
Does VitaSpring Biomedical Co. pay a dividend?
VitaSpring Biomedical Co. didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is VitaSpring Biomedical Co.’s book value per share?
VitaSpring Biomedical Co.’s book value is negative (−$0.02 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of July 31, 2026.
How much cash and debt does each share of VitaSpring Biomedical Co. have?
Each share of VitaSpring Biomedical Co. has $0.00 of cash and investments, as of July 31, 2026.
Has VitaSpring Biomedical Co. bought back shares?
VitaSpring Biomedical Co.’s share count rose about 419711% from 2017 to 2026. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.